Your browser doesn't support javascript.
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK.
Hill, Verity; Du Plessis, Louis; Peacock, Thomas P; Aggarwal, Dinesh; Colquhoun, Rachel; Carabelli, Alesandro M; Ellaby, Nicholas; Gallagher, Eileen; Groves, Natalie; Jackson, Ben; McCrone, J T; O'Toole, Áine; Price, Anna; Sanderson, Theo; Scher, Emily; Southgate, Joel; Volz, Erik; Barclay, Wendy S; Barrett, Jeffrey C; Chand, Meera; Connor, Thomas; Goodfellow, Ian; Gupta, Ravindra K; Harrison, Ewan M; Loman, Nicholas; Myers, Richard; Robertson, David L; Pybus, Oliver G; Rambaut, Andrew.
  • Hill V; Ashworth Laboratories, Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK.
  • Du Plessis L; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
  • Peacock TP; Department of Biology, University of Oxford, 11a Mansfield Rd, Oxford OX1 3SZ, UK.
  • Aggarwal D; Department of Biosystems Science and Engineering, ETH Zürich, Zürich, Switzerland.
  • Colquhoun R; Department of Infectious Disease, Imperial College London, London W2 1PG, UK.
  • Carabelli AM; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1RQ, UK.
  • Ellaby N; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Gallagher E; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Groves N; Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.
  • Jackson B; Ashworth Laboratories, Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK.
  • McCrone JT; Department of Medicine, University of Cambridge, Cambridge, UK.
  • O'Toole Á; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Price A; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Sanderson T; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Scher E; Ashworth Laboratories, Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK.
  • Southgate J; Ashworth Laboratories, Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK.
  • Volz E; Ashworth Laboratories, Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK.
  • Barclay WS; School of Biosciences, The Sir Martin Evans Building, Cardiff University, Cardiff CF10 AX, UK.
  • Barrett JC; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1RQ, UK.
  • Chand M; The Francis Crick Institute, 1 Midland Rd, London NW1 1AT, UK.
  • Connor T; Ashworth Laboratories, Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK.
  • Goodfellow I; School of Biosciences, The Sir Martin Evans Building, Cardiff University, Cardiff CF10 AX, UK.
  • Gupta RK; MRC Unit for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
  • Harrison EM; Department of Infectious Disease, Imperial College London, London W2 1PG, UK.
  • Loman N; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1RQ, UK.
  • Myers R; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Robertson DL; Guy's and St Thomas' Hospital NHS Trust, St Thomas' Hospital, Westminster Bridge Rd, London SE1 7EH, UK.
  • Pybus OG; School of Biosciences, The Sir Martin Evans Building, Cardiff University, Cardiff CF10 AX, UK.
  • Rambaut A; Pathogen Genomics Unit, Public Health Wales NHS Trust, Cardiff CF14 4XW, UK.
Virus Evol ; 8(2): veac080, 2022.
Article in English | MEDLINE | ID: covidwho-2051563
ABSTRACT
The first SARS-CoV-2 variant of concern (VOC) to be designated was lineage B.1.1.7, later labelled by the World Health Organization as Alpha. Originating in early autumn but discovered in December 2020, it spread rapidly and caused large waves of infections worldwide. The Alpha variant is notable for being defined by a long ancestral phylogenetic branch with an increased evolutionary rate, along which only two sequences have been sampled. Alpha genomes comprise a well-supported monophyletic clade within which the evolutionary rate is typical of SARS-CoV-2. The Alpha epidemic continued to grow despite the continued restrictions on social mixing across the UK and the imposition of new restrictions, in particular, the English national lockdown in November 2020. While these interventions succeeded in reducing the absolute number of cases, the impact of these non-pharmaceutical interventions was predominantly to drive the decline of the SARS-CoV-2 lineages that preceded Alpha. We investigate the only two sampled sequences that fall on the branch ancestral to Alpha. We find that one is likely to be a true intermediate sequence, providing information about the order of mutational events that led to Alpha. We explore alternate hypotheses that can explain how Alpha acquired a large number of mutations yet remained largely unobserved in a region of high genomic surveillance an under-sampled geographical location, a non-human animal population, or a chronically infected individual. We conclude that the latter provides the best explanation of the observed behaviour and dynamics of the variant, although the individual need not be immunocompromised, as persistently infected immunocompetent hosts also display a higher within-host rate of evolution. Finally, we compare the ancestral branches and mutation profiles of other VOCs and find that Delta appears to be an outlier both in terms of the genomic locations of its defining mutations and a lack of the rapid evolutionary rate on its ancestral branch. As new variants, such as Omicron, continue to evolve (potentially through similar mechanisms), it remains important to investigate the origins of other variants to identify ways to potentially disrupt their evolution and emergence.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Topics: Variants Language: English Journal: Virus Evol Year: 2022 Document Type: Article Affiliation country: Ve

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Topics: Variants Language: English Journal: Virus Evol Year: 2022 Document Type: Article Affiliation country: Ve